Short Communications 22
Translational - Others

[SC22-5] A new hope for multiple system atrophy: A translational research of a novel NMDAR receptor modulator from preclinical models to patients

*Da-Zhong Luo¹, Yu-Li Liu², Yufeng Jane Tseng^3,4,5,6, Wen-Sung Lai^1,7,8 (1. Department of Psychology, National Taiwan University, Taipei, Taiwan, 2. Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan, 3. Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan., 4. The Metabolomics Core Laboratory, Centers of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan., 5. Department of Computer Science and Information Engineering, National Taiwan University, Taipei, Taiwan., 6. School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan., 7. Graduate Institute of Brain and Mind Sciences, National Taiwan University, Taipei, Taiwan., 8. Neurobiology and Cognitive Science Center, National Taiwan University, Taipei, Taiwan.)

Keywords:Multiple system atrophy (MSA), Atypical Parkinsonism, D-amino acid oxidase inhibitor (DAOI), NMDA receptor, Drug Development in translational research